The antiretroviral therapy (ART) coverage among male adults living with HIV in France is forecasted to experience a gradual increase from 87% in 2024 to 90% by 2028. As of 2023, the coverage stood at an estimated 85%, marking a consistent effort to enhance treatment access. The year-on-year percentage increase highlights a steady improvement, particularly with a modest annual growth rate (CAGR) projected over this forecast period.

Future trends to watch for include:

Policy changes impacting accessibility and affordability of ART.
Technological advances in treatment delivery affecting coverage rates.
Shifts in public health initiatives aimed at further increasing coverage rates among diverse male populations.